2023
DOI: 10.1186/s12974-023-02798-7
|View full text |Cite
|
Sign up to set email alerts
|

IL-10 production by granulocytes promotes Staphylococcus aureus craniotomy infection

Abstract: Background Treatment of brain tumors, epilepsy, or hemodynamic abnormalities requires a craniotomy to access the brain. Nearly 1 million craniotomies are performed in the US annually, which increase to ~ 14 million worldwide and despite prophylaxis, infectious complications after craniotomy range from 1 to 3%. Approximately half are caused by Staphylococcus aureus (S. aureus), which forms a biofilm on the bone flap that is recalcitrant to antibiotics and immune-mediated clearance. However, the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 77 publications
0
2
0
Order By: Relevance
“…In addition, the large bacterial biomass associated with biofilm elicits continued proinflammatory mediator release, which would perpetuate the G-MDSC inhibitory loop. Another contributing factor is the induction of a robust IL-10 response during S. aureus biofilm infection that promotes infection persistence [ 93 , 99 ]. Therefore, a better understanding of how leukocytes are seemingly refractory to the antimicrobial actions of proinflammatory cytokine stimulation during S. aureus biofilm infection may help to “flip the switch” to reprogram cells for enhanced bactericidal activity [ 120 ].…”
Section: Lactate Released From S Aureus Biofilm Pr...mentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, the large bacterial biomass associated with biofilm elicits continued proinflammatory mediator release, which would perpetuate the G-MDSC inhibitory loop. Another contributing factor is the induction of a robust IL-10 response during S. aureus biofilm infection that promotes infection persistence [ 93 , 99 ]. Therefore, a better understanding of how leukocytes are seemingly refractory to the antimicrobial actions of proinflammatory cytokine stimulation during S. aureus biofilm infection may help to “flip the switch” to reprogram cells for enhanced bactericidal activity [ 120 ].…”
Section: Lactate Released From S Aureus Biofilm Pr...mentioning
confidence: 99%
“…In general, G-MDSCs exert their suppressive activity through ROS and arginase 1 (Arg-1), whereas M-MDSCs use iNOS and anti-inflammatory cytokines such as IL-10 and TGF-β to inhibit T cell responses [86][87][88]. G-MDSCs play a pathological role in mouse models of S. aureus infection by inhibiting proinflammatory responses, leading to increased bacterial survival [21, [89][90][91][92][93] and G-MDSCs have also been shown to accumulate at the site of prosthetic joint infection (PJI) in humans [94]. A recent study reported that glycolysis was important for driving G-MDSC maturation into PMNs in a mouse model of systemic S. aureus infection, although this had no effect on bacterial burden [95].…”
Section: Metabolism Shapes Myeloid-derived Suppressor Cells During S ...mentioning
confidence: 99%